HCV prophylactic vaccine (University of Adelaide)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHCV prophylactic vaccine (University of Adelaide)

Drug Alias NameHCV prophylactic vaccine (perforin adjuvanted)丙型肝炎预防疫苗 (阿德莱德大学)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Adelaide

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Adelaide

Inactive CompaniesN/A

Active IndicationsHepatitis C

Inactive IndicationsN/A

Other Information

ATC CodeN/A